The 3 mg tier is the lowest strength most brands sell, and at least one manufacturer markets it explicitly as the range for people new to pouches — but “low strength” describes the peak, not the dose. A 3 mg pouch reaches roughly 60% of a cigarette’s peak blood nicotine and then sits there for an hour. It suits someone who wants a long, flat, undramatic delivery. It is not a safety tier, and on most cans “3 mg” does not tell you a concentration at all.
I have come to think the 3 mg tier is the most misunderstood number in this category, for a reason that has nothing to do with the number itself: almost nobody states what it is 3 mg of what. Five of the six brands I checked print a bare milligram figure with no denominator. One brand’s own table shows a 3 mg pouch and a 6 mg pouch at identical concentration.
So this page does two things. It sets out who actually sells a 3 mg tier and what their own sites say, and then it takes the delivery data seriously — because the delivery data says something more interesting than “it’s the weak one”.
Who actually sells a 3 mg tier
Fewer brands than you’d assume, and they disagree about what the bottom of the ladder is.
ZYN in the United States sells exactly two strengths: ZYN Nicotine Pouches are available in two nicotine strengths: 3 milligrams and 6 milligrams.
Ten flavours are listed as available nationwide — Chill, Cinnamon, Citrus,
Coffee, Cool Mint, Menthol, Peppermint, Smooth, Spearmint and Wintergreen
— plus three later additions at the classic 3 mg and 6 mg strengths.
So 3 mg is half of ZYN’s entire US range.
ZYN in the UK is a different product line with seven tiers, and 3 mg is not the floor. Its own shop navigation reads Shop ZYN Low—New to nicotine pouches? Shop our 1.5mg & 3mg ranges.
, then Already a nicotine pouch user? Shop our 6mg & 9mg ranges.
, then Experienced nicotine pouch user? Shop our 11mg, 13.5mg & 16.5mg ranges.
That is an explicit experience ladder with 3 mg placed at the beginner end — and it is also shop navigation, so treat it as marketing as much as guidance.
Nordic Spirit publishes the most useful specification of any brand I’ve found, because it gives both denominators. Mellow mini is 4mg of nicotine per pouch / 9mg of nicotine per gram
; Regular mini is 3mg of nicotine per pouch / 9mg of nicotine per gram
; Regular standard is 6mg of nicotine per pouch / 9mg of nicotine per gram
.
Pablo runs 3 mg as its lowest collection — four products, Chill, Classic, Original and Smooth — inside a range the brand describes as ranging from 3-24mg.
VELO, on its Swedish site, has no 3 mg tier at all; 6 mg is the floor. Rogue publishes nothing about strength on its own domain. And on!, which publishes nothing to consumers anywhere, is documented by FDA as selling 2 mg and 4 mg products — so the sub-3 mg band exists, sourced to a regulator rather than a brand.
“3 mg” is not a strength until you know the denominator
Look again at Nordic Spirit’s own numbers. The 3 mg Regular mini and the 6 mg Regular standard are both 9 mg of nicotine per gram. The difference between them is not strength. It is pouch mass. The mini is simply a smaller pouch of the same material.
That is the whole trap in one brand’s spec sheet, and it generalises. ZYN US is the only brand I found that publishes a pouch weight — One ZYN pouch weighs approximately 0.4 grams.
— which puts its 3 mg product at 7.5 mg/g on my arithmetic, not the brand’s. Everyone else gives you a milligram figure and no mass, so you cannot convert.
| Brand | Unit stated? | Pouch weight published? | Lowest tier |
|---|---|---|---|
| ZYN (US) | Bare “mg”, no denominator | Yes — approx. 0.4 g | 3 mg |
| ZYN (UK) | Bare “mg”, no denominator | No | 1.5 mg |
| Nordic Spirit | Both mg/pouch and mg/g | No (derivable) | 3 mg |
| VELO (Sweden) | Bare “MG”, no denominator | No | 6 mg |
| Pablo | Bare “mg”, no denominator | No | 3 mg |
| Rogue | Nothing published | No | Not published |
For scale, the German federal risk assessor BfR measured a sample of the market and reported that The median weight per pouch was 0.6 g and the nicotine content per pouch was 9.48 mg. The highest nicotine content was 47.5 mg per pouch and the lowest was 1.79 mg per pouch
. So the category floor sits below 3 mg, and the median product is roughly three times a 3 mg pouch. I’ve written the full arithmetic up in mg per pouch vs mg per gram.
What a 3 mg pouch actually delivers
Here is the table everyone quotes half of. It is Table 1 from a UK Committee on Toxicity discussion paper, Toxicokinetic parameters for nicotine-containing products
, and the column people skip is the one on the left.
| Product | Nicotine (mg) | AUC0–120 (ng/h/ml) | Cmax (ng/mL) | tmax (h) | Study |
|---|---|---|---|---|---|
| Conventional cigarette | 14.6 | 14.8 | 12.8 | 0.117 | Digard 2013 |
| Nicotine gum | 4.2 | 13.1 | 9.1 | 0.75 | Digard 2013 |
| Pouched snus | 10.7 | 16.8 | 10.8 | 1.0 | Digard 2013 |
| Snus | 8.0 | 45.9 | 10.6 | 1.15 | Lunell 2020 |
| Nicotine pouch | 3.0 | 32.0 | 7.7 | 1.02 | Lunell 2020 |
| Nicotine pouch | 6.0 | 57.7 | 14.7 | 1.1 | Lunell 2020 |
The peak is the reassuring number: 7.7 against a cigarette’s 12.8, about 60%. The shape is where the interest is. A cigarette peaks at 0.117 hours — about seven minutes — and falls away. The 3 mg pouch peaks at 1.02 hours and is in your mouth the whole time. BfR, describing the same study, puts the 3 mg peak at 61 minutes with a half-life of 152 minutes.
Low peak, long plateau. A 3 mg pouch is not a scaled-down cigarette; it is close to the opposite delivery profile.
Now the caveat, because it matters and I don’t think it gets made. The cigarette row and the 3 mg pouch row come from different studies. You can see the problem inside the table itself: Digard’s pouched snus at 10.7 mg gives an AUC of 16.8, while Lunell’s snus at 8.0 mg gives 45.9. That is roughly a 2.7-fold disagreement about snus between two studies sitting in the same regulator’s table. So I would not tell you a 3 mg pouch delivers “2.2 times a cigarette’s total exposure”, even though 32.0 ÷ 14.8 says exactly that. What survives the disagreement is the shape — every pouch and snus row peaks around an hour, every cigarette row peaks in minutes — and the honest conclusion is that a 3 mg pouch’s total exposure is at least comparable to a cigarette’s, despite containing a fifth of the nicotine.
Every published 3 mg figure traces to one manufacturer-financed study
This is the limitation that ought to travel with the numbers above. BfR and COT both report 3 mg and 6 mg pharmacokinetics, and both are quoting the same paper — Lunell et al. 2020, on one manufacturer’s product.
BfR says so itself, twice, and it is better to have a regulator say it than to infer it from an author list: A recent study from Sweden has investigated the pharmacokinetics of nicotine from nicotine pouches [17]. In this study, financed by a manufacturer, three nicotine strengths were investigated.
And again: Further effects on test subjects were also examined in a study, in which a manufacturer also participated
.
So when you read that a 3 mg pouch gives a Cmax of 7.7 ng/mL, you are reading one study, financed by a manufacturer, measured on that manufacturer’s own product. It is the best data there is. It is not independent corroboration, and anyone citing BfR and COT as two sources is citing one.
3 mg is not a safety tier, and three regulators say so differently
The strongest finding in the BfR opinion for anyone choosing a low strength is about irritation, not nicotine: While the tobacco cigarette rarely caused irritation to the oral mucosa, all nicotine pouch users reported oral mucosa irritation ranging from moderate (0–20 mg nicotine) to severe (30 mg).
Read the band. “Moderate (0–20 mg nicotine)” includes the 0 mg placebo pouch. The pouch matrix irritates the mouth independently of how much nicotine is in it, which means dropping to 3 mg does not buy you out of that. Pouch pH runs alkaline — BfR’s median was 8.8, with a median free-base fraction of 86% — and that is the obvious candidate mechanism, though no source I have found tests pH against irritation directly.
Heart rate tells a similar story about variation. BfR’s table gives a maximum increase of 8.5 bpm (median) at 3 mg against 10.5 at 6 mg and 11.0 for 8 mg snus — but the 3 mg range runs to 18.0 bpm, above both of the other medians. Tier averages hide people.
And two regulators do not treat low strengths as a separate case at all. Germany’s position, per BfR, is that pouches are an unauthorised novel food and that at the acute reference dose nicotine pouches containing all nicotine quantities presented in this report will be withdrawn from the market
— a report whose own floor was 1.79 mg per pouch. The Netherlands set its threshold at 0.035 mg, which a 3 mg pouch exceeds by a factor of about 86.
What the law thinks a strength is
Three neighbouring European countries cap pouch nicotine in three incompatible units, which is the denominator problem again, this time in statute.
- Denmark caps per pouch:
Nikotinposer må maksimalt indeholde 9,0 mg nikotin pr. pose.
— BEK nr. 249 of 4 March 2025, in forceden 1. juli 2025.
- Czechia caps per dose and per packet:
One nicotine pouch dose may contain a maximum of 12 mg of nicotine.
andA unit packet must not contain more than 240 mg of nicotine
, Decree No 141/2023 of 16 May 2023. - Poland‘s Ministry of Health announced in January 2025 that the maximum would be limited to 20 mg/g. That is a ministry announcement in the future tense, not statute text I was able to read, so treat the figure accordingly.
- Sweden, the largest market, sets no maximum nicotine content in Lag (2022:1257) at all — only an 18 age limit and a delegation to product regulations.
- The UK likewise sets no numerical cap. The Tobacco and Vapes Act 2026 contains powers to regulate contents, but the operative change is an age of sale: from 29 October 2026 it becomes an offence to sell any nicotine product to anyone under 18.
A per-gram cap behaves differently from a per-pouch cap depending on pouch mass. On BfR’s median 0.6 g pouch, Poland’s 20 mg/g would permit about 12 mg per pouch — a third more than Denmark allows. On a 0.4 g ZYN-sized pouch it would permit about 8 mg. That arithmetic is mine, not any regulator’s.
One widely cited figure I could not verify: PAS 8877:2022 is said to recommend a 20 mg per-pouch limit. The free preview of the standard gives its scope — it does set limits for nicotine contents, pH characteristics and water activity of the pouches
— but the number itself sits in a paywalled clause, so I am not quoting it. Worth knowing either way: the preview states that the document was sponsored by BAT UK Ltd.
, with Philip Morris, JTI and Swedish Match among the steering group, and that Compliance with a PAS cannot confer immunity from legal obligations.
It is an industry-sponsored specification, not law.
Nobody caps a day’s use — except the medicine
Across ZYN US, ZYN UK, VELO, Nordic Spirit, Pablo and Rogue, not one publishes a daily maximum, a maximum number of pouches, or any ceiling at all. The only thing they publish is duration, and they don’t agree on that either: ZYN US says up to one hour
while ZYN UK says Most nicotine pouches last around 25 to 30 minutes
— the same brand, two markets.
The contrast is a licensed product. The 4 mg Nicorette lozenge, same route and a comparable per-unit dose, carries a cap in its regulated label: Most patients require 8 to 12 lozenges per day, not to exceed 15 lozenges.
On COT’s table a 4.2 mg nicotine gum has a lower AUC than a 3 mg pouch. A medicine with less total exposure per unit has a number on the box; the pouch has none.
I am not drawing a safety conclusion from that, and neither should you. It is a regulatory difference — medicines carry dosing instructions because they are licensed as medicines — but it is the single clearest frame I know for what the 3 mg tier does and does not come with.
A gap worth knowing about
There is no published measurement of label accuracy at the 3 mg tier. The one analytical study I found that weighed label against content covers products from 6 mg to 9.4 mg — it reported a labelled 6 mg ZYN at 5.4 mg and a labelled 7 mg VELO at 4.6 mg by GC-FID, n=3. Every author of that paper is an employee of Altria Client Services LLC, a pouch manufacturer, and the published page carries neither a funding statement nor a competing-interests statement.
Extrapolating those shortfalls down to 3 mg would be guessing, so I won’t. The honest position is that nobody has published what is actually in a 3 mg pouch.
So who is the 3 mg tier for?
On the evidence, it suits an adult nicotine user who wants a long, low, flat delivery rather than a hit — someone stepping across from a product with a sharper peak, or someone who finds higher strengths uncomfortable. ZYN UK’s own answer to discomfort is to go lower: To minimize the intensity of the tingling effect, try pouches with a lower strength
.
Who it is not for: anyone treating a low number as a low dose. The total exposure from a 3 mg pouch is in the same territory as products containing several times the nicotine, because you hold it for an hour. And it is not a tier for people who do not currently use nicotine — COT’s position on that is unambiguous: Individuals who have never been exposed to nicotine and who take up the use of oral nicotine pouches would be at risk from effects of nicotine to which they would not otherwise be exposed. This includes the risk of addiction.
Frequently asked questions
Is 3 mg a weak pouch?
Weak at the peak, not necessarily in total. COT’s table gives a 3 mg pouch about 60% of a cigarette’s peak blood nicotine, with the peak arriving around an hour instead of seven minutes, and a total two-hour exposure at least comparable to a cigarette’s.
Is 3 mg the lowest you can buy?
No. ZYN UK sells a 1.5 mg range, FDA’s authorised list records on! products at 2 mg, and BfR’s survey of the market found a product at 1.79 mg per pouch.
Why do two 3 mg pouches from different brands feel different?
Most likely pouch mass and pH rather than nicotine. Nordic Spirit’s own figures show a 3 mg mini and a 6 mg standard at the same 9 mg/g, and BfR found free-base nicotine fractions varying widely across the market.
How many 3 mg pouches a day is too many?
No manufacturer publishes a number, and no regulator sets one for pouches. The nearest published ceiling for any oral nicotine product is the 4 mg Nicorette lozenge’s “not to exceed 15 lozenges” — a different product under a different regime.
Does a 3 mg pouch irritate less?
Not on BfR’s data. Its moderate-irritation band is stated as 0–20 mg nicotine and includes the 0 mg placebo pouch, which means the matrix irritates whatever the strength.
Sources
- UK Committee on Toxicity, TOX/2022/22,
Toxicokinetic parameters for nicotine-containing products
, Table 1, March 2022 — cot.food.gov.uk. A discussion paper carrying the standing note that it does not represent the committee’s settled views. - UK Committee on Toxicity, statement on the bioavailability of nicotine from oral nicotine pouches, statement 2023/01, February 2023 — cot.food.gov.uk.
- BfR, Health risk assessment of nicotine pouches, Opinion no. 023/2022, 7 October 2022 — bfr.bund.de.
- Bekendtgørelse om grænseværdier for nikotinindhold i tobakssurrogater, BEK nr. 249 of 4 March 2025 — retsinformation.dk.
- Czech Decree No 141/2023 of 16 May 2023 on tobacco-free nicotine pouches, English text — EU TRIS.
- Lag (2022:1257) om tobaksfria nikotinprodukter — Sveriges riksdag.
- UK government guidance, Selling vaping and nicotine products, last updated 12 August 2026 — gov.uk; Tobacco and Vapes Act 2026 — legislation.gov.uk.
- PAS 8877:2022, free preview (scope, contents and sponsorship) — ANSI webstore.
- Nicorette Cools 4 mg Lozenge, Summary of Product Characteristics, text revised 9 June 2026 — electronic medicines compendium.
- FDA, Nicotine Pouch Products Authorized by FDA, content current 21 August 2026 — fda.gov.
- Platt SP et al., Dissolution and physical characterization of oral nicotine pouch products, Scientific Reports 16:4406, 6 January 2026 — nature.com. All authors are employees of Altria Client Services LLC; no funding statement and no competing-interests statement appear on the published page.
- Manufacturer specifications (commercial sources): ZYN US FAQ, ZYN UK FAQ, Nordic Spirit FAQ, Pablo, VELO Sweden, Rogue.
Related reading on this site: the complete mg guide, choosing your first strength, what “extra strong” actually means, how to step down your strength, snus vs dip vs chew, and the master ranking.